Health: RSV Immunisation

Lord Blunkett Excerpts

Wednesday 17th January 2024 Lords Chamber

[Lord Markham (Con)]

My noble friend is quite right. If we take the shingles one, we see quite a disparity. The 70 to 75 element of the programme has a 74% take- up while the 65-plus element has only a 41% take-up—so there is a huge difference. We are starting to collect the data so that we can understand those disparities and then, as I mentioned in answer to the previous question, make sure that we have an action plan to address those groups.

[Lord Blunkett (Lab)]

My Lords, I congratulate my noble friend Lady Ritchie on her tenacity and declare a selfish interest in that I have had this wretched virus two winters running. I will be able to buy the vaccine later this year if it is not available otherwise, but millions of people, including those supporting infants, will not. That is a disgrace, is it not?

[Lord Markham (Con)]

As I say, we are looking to have an infant programme. It is vital in the first few weeks for babies, which is why we are doing this whole plan, thanks to the pressure and the medical evidence. I echo what has been said about the relentless campaign for it all by the noble Baroness, Lady Ritchie. We have got a tender in place. The intention is that we will be rolling it out from the autumn. I repeat that there is only one other public vaccination programme on this so far, in Galicia in Spain, so we really are at the forefront of this programme.

Adult Social Care: Challenge Procedures

Lord Blunkett Excerpts

Wednesday 19th April 2023 Lords Chamber

[Lord Markham (Con)]

Again, this goes to the point about the massive increase we have put in place of £7.5 billion. I have not heard of but would be pleased to hear about any plans on the other side of the House to increase that funding, since £7.5 billion is a very large figure—a 20% increase. Clearly, we will continue to review whether more is needed; we have put in increases each year. The importance of ensuring social care provision is completely understood.

[Lord Blunkett (Lab)]

My Lords, can the Minister clarify his last answer? In replying to me on a previous occasion, he conceded that a very substantial part of the money he has just announced is from local authority council tax. Can he confirm that?

[Lord Markham (Con)]

Yes, absolutely; a large part of it is from central government funding and a large part is from local authority funding, given local authorities’ ability to use a precept and increase council tax. Of the 153 local authorities, 151 have taken that opportunity to increase the council tax.

Adult Social Care

Lord Blunkett Excerpts

Thursday 24th November 2022 Lords Chamber

[Lord Markham (Con)]

I thank my noble friend. I think we agree that, where care can be considered and put in place in the community, that has to be the best place to do it. These funds are not just limited to care homes. The whole reason that they are allocated through local authorities is that it allows them to put the money where it is most needed in their local area. I have to say at this point that, despite all the issues we talk about, 89% of people are satisfied with the care they receive and 64% or so are very or extremely satisfied. In the context of all this, we have to recognise that the numbers are showing us that this is a service that people are satisfied with.

[Lord Blunkett (Lab)]

My Lords, in following up the question raised by the noble Lord, Lord Forsyth, perhaps the Minister could outline to us the ratio of spend over the next two years in relation to what is being raised from council tax and what is actually coming from the Exchequer.

[Lord Markham (Con)]

Of the £2.8 billion increase next year, £1 billion is coming through the grant, with the other £1.8 billion available for the local authorities. In 2024-25, of that £4.7 billion, £1.7 billion is coming through the central grant.

NHS: Backlogs

Lord Blunkett Excerpts

Wednesday 9th November 2022 Lords Chamber

[Lord Markham (Con)]

Thank you. I am sure the whole House will agree the need for efficiencies to make sure every pound is well spent. I have a little knowledge in the DWP space. Although it falls outside my responsibilities now, I was the lead NED there and I know that the team worked very hard during the pandemic to make sure that universal credit reached people quickly, and as a result they did not proceed with as many checks as they would do normally. It was deliberate policy to make sure money was paid quickly to those who needed it. At the same time, they absolutely understand that they need now to get on top of it and it is key to their action because, as my noble friend says, the more money we can free up in other departments, the more we can focus it on the front line where we really need it.

[Lord Blunkett (Lab)]

My Lords, I recognise that the noble Lord is new in post and the Secretary of State is sort of new, having been in and out and then back again. But the backlog in repairs is mirrored by the exponential increase in waiting lists. Has this something to do with the atrophy that now exists in the health service due to the changes brought in by Matt Hancock, which have led not to the integration of services but the integration of bureaucracy?

[Lord Markham (Con)]

I can assure the noble Lord that bureaucracy is not the aim of the game and that getting money to the front line is the priority. We have record levels of investment in this area. We are currently devoting about 12% of GDP to health spending, which sits alongside the highest in the world. That is not to say we do not have to make sure every penny of that is spent effectively and, where possible, on the front line rather than on back office and bureaucracy.

Covid-19: Aligning UK and Foreign Entry and Return Requirements

Lord Blunkett Excerpts

Monday 19th July 2021 Lords Chamber

Asked by

[Lord Blunkett]

To ask Her Majesty’s Government what discussions they have had with the governments of countries with (1) low levels of COVID-19 infections, and (2) a traditionally high number of visitors from the United Kingdom, to seek to align the requirements for (a) vaccination, and (b) testing on entry and return.

[Lord Blunkett (Lab) [V]]

I hope for the last time virtually, I beg leave to ask the Question standing in my name on the Order Paper and draw attention to my declaration on the register.

[The Parliamentary Under-Secretary of State, Department of Health and Social Care (Lord Bethell) (Con) [V]]

My Lords, the Government are working with a range of international partners to ensure a safe return to international travel while managing public health risks. We are taking a phased approach to amending requirements for passengers fully vaccinated through the UK programme and exploring plans to remove quarantine for non-UK residents arriving from amber countries from later this summer. The purpose of our inbound travel—[Inaudible]—while ensuring that our route out of the international travel restrictions is sustainable.

[Lord Blunkett (Lab) [V]]

My Lords, at home and abroad, freedom day is in danger of turning into confusion day. Surely people should not be punished in any way for wanting, for business or for pleasure, to leave and return to our country freely. Clarity, consistency and some sort of understanding of the impact on our foreign relations would surely not only help but save our aviation and travel industry. Would the Minister agree that discussion with our friends could have led to an understanding of the constitution of the French Fifth Republic and avoided the need to invent amber-plus, thereby enabling us to be able to treat the French as they would treat us, given that our infection levels are pretty much at amber-plus?

[Lord Bethell (Con) [V]]

My Lords, I completely agree with the noble Lord that we should be utterly committed to the route to sustainable, open borders. However, we cannot hide from the threat of infection from abroad. That infection comes from higher rates from abroad—the positivity rates of some countries have been in the high teens—but also the threat of variants of concern, particularly the vaccine-evading beta variant, which is highly prevalent in some countries, including, increasingly, France.

Health: Dementia

Lord Blunkett Excerpts

Monday 5th July 2021 Lords Chamber

[Lord Bethell (Con)]

My noble friend makes a very touching and constructive point, because social engagement and involvement in the community keep older people sharp and their brains engaged and help stave off the ravages of age and the diminution of mental faculties. We all have a role to play in supporting the elderly and those with mental challenges. My noble friend is entirely right to call on the entire community to step up to that role.

[Lord Blunkett (Lab) [V]]

I draw attention to my declaration in the register as a dementia champion. The corollary of the question that has just been put is that reduced contact, reduced socialisation and reduced activity accelerate the onset of dementia. Of course, that has been happening over the past 16 months. Will the Minister commit to investing in the voluntary and charitable sector in this area so that it too can play its part in supporting families and helping it to reaccelerate back into social action?

[Lord Bethell (Con)]

I accept the noble Lord’s point. The corollary is right: there are those who have not had the engagement they once had, and it is fair to assume that that has accelerated their decline. The role of charities and communities in trying to provide that back-up support is critical. That is why we have provided £515,000 to the Alzheimer’s Society to support its Dementia Connect programme.

Covid-19: Proof of Vaccination

Lord Blunkett Excerpts

Monday 14th June 2021 Lords Chamber

Asked by

[Lord Blunkett]

To ask Her Majesty’s Government what facility they will make available as proof of vaccination for those wishing to travel who do not have a smart phone and access to the verification app.

[The Parliamentary Under-Secretary of State, Department of Health and Social Care (Lord Bethell) (Con)]

My Lords, since May, individuals in England who have had two doses of an approved Covid-19 vaccine have been able to demonstrate their vaccine status for international travel. The services can be accessed through digital and non-digital routes, via the NHS app and the NHS website or by calling 111 to request a letter. The devolved Administrations are making available similar letters for use in travelling overseas. Over 63,000 people have requested a letter since the service was launched.

[Lord Blunkett (Lab) [V]]

I am very grateful to the Minister for his positive answer. Can he tell the House exactly how long it takes to get a printed letter as opposed to downloading the app, and how this will relate to the new electronic travel authorisation, which hopefully will coincide with lifting restrictions on British travellers here and abroad?

[Lord Bethell (Con)]

My Lords, 57,000 people have received their letters so far. I am not aware of any delays. Those who wish to can use a pharmacy for the delivery of their letters. It is encouraging news and we have gone to considerable lengths to meet the suggestions of charities which we engaged with on the letters. They are available in different languages and in Braille.

Heathrow Airport: Border Control Passenger Safety

Lord Blunkett Excerpts

Tuesday 25th May 2021 Lords Chamber

[Lord Bethell (Con)]

My Lords, the noble Lord is right: this is a 21st-century problem that we may well be living with for the rest of our lives. It is absolutely right that we look at the best and latest technology to try to mitigate risk and reduce the impact on the things that we love doing, including global travel. However, the image that he cited is a little far away at the moment, I am afraid: we are struggling to get accurate tests from a gob of spit, let alone from the air in an airport cabin. However, we are meeting with the firms who are investigating these kinds of technologies; that is done through the innovations and partnerships department of test and trace, and we are hopeful that those technologies will emerge.

[Lord Blunkett (Lab)]

My Lords, I draw attention to my interests in the register. It is very welcome that red-list passengers will now be separated, but, the longer the queues, the more likely the infection is to spread. It cannot be right to take 10 minutes per passenger to clear them through the system. Surely we can use the kind of evidence that is being used in other parts of the world, get our act together and, with the help of this excellent Minister and the noble Baroness, Lady Williams, put pressure on the Health Secretary and the Home Secretary to put even more resource in, and, above all, use technology and the experience in the rest of the world to get this right.

[Lord Bethell (Con)]

The noble Lord is entirely right: this is exactly what we have sought to do—namely, to front-end a huge amount of the administrative burden into the passenger landing form through the CMS computer system so that all the bookings, details and testing are pre-prepared before anyone arrives in the terminal. None the less, travel in the days of a pandemic is a complicated affair. Some people are trying to skip out on their responsibilities, and therefore there is an administrative burden. We hope to roll out e-gates for both the amber and red lists, once the red-list terminals are open. This will take a great pressure off the passenger point.

Health Protection (Coronavirus, International Travel) (England) (Amendment) (No. 7) Regulations 2021

Lord Blunkett Excerpts

Monday 22nd March 2021 Lords Chamber

[Lord Blunkett (Lab) [V]]

My Lords, I am very proud to follow my noble friend and to offer her the warmest possible welcome to this House. I congratulate her not only on an excellent maiden speech but on the ability to get so much into such a short period. The time constraint has not prevented her presenting a picture of what has happened and what must happen in a way that I would have been proud to have delivered myself. I warmly welcome what she said and I hope that she will forgive me—because she spelled out why—for remarking that this is one of those very rare occasions when I can say that I wish that someone was not on our Benches but was instead down the Corridor. But I am very pleased that she is here and that she will make a continuing contribution, as she has described, to Labour taking its full place once again as the Government of our country.

I am diffident about the short time I have available, because my noble friend Lady Thornton was well ahead of me in understanding the extent of the impact of the virus over 12 months ago. I pay tribute to her for that. I agree entirely about process and procedure, but I share the concerns of the noble Baroness, Lady Altmann, about where we are going. As she rightly said, we have those delivering to all of us both essential goods and equipment across the country on a daily basis, and by necessity coming in to deliver what otherwise would not be possible. I simply put this on the table: if the vaccine is safe and successful—I believe that it is—and if the upgraded PCR tests are to be as successful as I know they will be, we will need to find new ways of being able to open our economy, to trade again, to keep people in jobs and to ensure that the economy of the future is secured.

The doom and gloom merchants must be very careful in what they say and how they say it in the months ahead because, quite honestly, enforcement is one thing but compliance is another, and we need the people of this country to feel optimism and hope, because the world is going to have to live with this virus—but live with it safely—for a long time to come.

Human Medicines (Amendment etc.) (EU Exit) Regulations 2020

Lord Blunkett Excerpts

Wednesday 2nd December 2020 Lords Chamber

[Lord Blunkett (Lab)]

My Lords, I was going to make an esoteric and wide-ranging speech on the relationship between the protocol, the MHRA and the European Medicines Agency and wow the gathered hundreds of online Peers in order to demonstrate my technical knowledge, but I have abandoned that in favour of saying something very brief on the relationship between these regulations and the Bill to which the Minister has already referred, and on today’s announcement about the purchase of the Pfizer BioNTech vaccine.

I genuinely congratulate the Minister—he must have had nightmares over the last eight months of Questions and Statements on PPE, test and trace, and everything else—on actually managing to find the time to be entirely on top of, and extremely impressive in, the process of taking through the somewhat delayed legislation on medical devices. I also congratulate him on his willingness to be flexible. It is easier to be flexible with one’s own side, but I actually am impressed that he, on behalf of the Government, has been able to respond so effectively to the superb campaign of the noble Baroness, Lady Cumberlege, in relation to the protections that we debated in Grand Committee. I know that my noble friend on the Front Bench has done a sterling job in supporting and working on that.

I want to test out this afternoon—in relation to what we are debating, because it is directly related to it, although it will be the subject of a Statement tomorrow—the extraordinary misunderstandings that appear to exist not just on the twittersphere, which you would expect because the very word “Twitter” brings that to mind, but in social media and the broadcast media as well. These relate to the relationship between the MHRA and the European Medicines Agency, and the relationship between what is possible now and what might change following the final conclusion of whatever deal is done at the end of the transition period in respect of our exit from the European Union at the end of December.

Perhaps the Minister—and this is a kind of run-out for tomorrow, seeing as there are so few of us gathered together—could confirm that the MHRA has powers, and has used them already when we were, and remain in the transition period, members of the European Union, in circumstances where it was appropriate to act swiftly when the European Medicines Agency was taking a longer period of time to come to a judgment on the efficacy of a particular procedure or vaccine. Regulation 137, I think, relates to this. Would it not be nice if we could join the German ambassador in welcoming international collaboration, rather than always having to believe that when we borrow someone else’s horse we should get commended for riding it in in front of the others? I am very supportive of what has been done; I believe that the MHRA has done its job thoroughly and efficaciously. It is excellent that we have been able to move quickly, not least because we might be able to transport the vaccine during December, before whatever chaos exists from 1 January. It is a great move forward; we should all celebrate it, but we should do so within the context of the reality of the situation, the knowledge of what existed already, the relationship of continuity after 1 January and the celebration of international collaboration to tackle the virus which, after all, is a pandemic.